CTMX 250117 3.00P (CTMX250117P3000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CTMX250117P3000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 24 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

SNY's Subcutaneous Sarclisa Proves Non-Inferior to IV Formulation (Revised)
Zacks Jan 14 04:05 ET
CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswireJan 8 08:00 ET
Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.25
Moomoo NewsJan 8 05:36 ET · Ratings
Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $5
Moomoo NewsJan 7 09:31 ET · Ratings
CytomX Therapeutics (CTMX) Receives a Buy From Wedbush
TipRanksJan 7 09:06 ET · Ratings
Express News | CytomX Therapeutics Inc : Wedbush Cuts Target Price to $5 From $8
ReutersJan 7 06:57 ET

Comments

watuzzi

Jan 13 04:12

$CytomX (CTMX.US)$ 18% pre market?

Jaguar8

Jan 6 15:16

NEWS ER

$CytomX (CTMX.US)$
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
Monday, 6th January at 4:05 pm
- Encouraging progress supports near-term focus on lead wholly-owned program, CX-2051 (EpCAM PROBODY® ADC). Initial Phase 1a clinical data in advanced metastatic colorectal cancer (CRC) are anticipated in the first half of 2025 -
- Early-stage research and platform capabilities to be concentrated on existing and potential future partnerships dur...

Trytosaveabit

Jan 6 15:14

Nice!

$CytomX (CTMX.US)$ CytomX Therapeutics: Ended 3Q With $117.6M of Cash, Cash Equivalents and Investments >CTMX
Dow Jones· 1 min ago

watuzzi

Jan 5 19:45

$CytomX (CTMX.US)$ this stock is undervalued.🚀🚀🚀

Trytosaveabit

Dec 3, 2024 06:01

Watching for data outadis!

$CytomX (CTMX.US)$ CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference! December 4 at 8AM est!